Lexaria Bioscience Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTEC


092920 Lexaria Bioscience Receives Condi
.
Download • 89KB

Recent Posts

See All

Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2020 by Medical and Pharma Insider and FC Global Strategies LLC